Ultivent™ Cozycap

Ultivent™ Cozycap

Ultivent™ Cozycap

Glycopyrronium + Indacaterol
Anticholinergic + Beta-2 stimulant (Antiasthma)

Indication:

Maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD)

Dosage & Administration:

Ultivent is recommended for once-daily administration at the same time each day.
Ultivent Cozycap capsules must be administered only by the oral inhalation route and only
using the revolizer device. Ultivent Cozycap capsules must not be swallowed. If a dose is
missed, it should be taken as soon as possible. Patients should not take more than one dose in a day.

Preparation:

Each pack contains 18 Cozycaps.